Quebec bill would force Netflix, other streaming giants to add more French-language content
Bill 109 would impose quotas on online streaming services like Disney, Spotify and others to make French-language content more visible and accessible for users.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
National Post
3 hours ago
- National Post
Nicoya Acquires Applied Photophysics, Expanding Biologics Characterization Capabilities for Faster Time-to-Clinic and Reduced Late-Stage Failures
Article content Doubles Revenue, Triples Customer Base; Acquisition Positions Nicoya as a Leading Provider of Integrated Biologics Characterization Platforms, Establishes European Hub Article content KITCHENER, Ontario — Nicoya Lifesciences, Inc., a leading provider of advanced biologics characterization tools for drug discovery and development, today announced its acquisition of Applied Photophysics, a UK-based provider of biophysical characterization instrumentation. Applied Photophysics, bringing a 50-year history of delivering established analytical methods and reliable instrumentation, will now operate as part of Nicoya. Article content Article content The acquisition is expected to immediately double Nicoya's annual revenue, triple its existing customer base, and provide a foundation for substantial profitability with continued organic growth projected at 25%. Article content As part of the integration, Applied Photophysics's UK headquarters in Leatherhead, Surrey, will become Nicoya's European operational hub. This significantly expands Nicoya's global reach and customer support capabilities. The acquisition was financed by Nicoya's existing investor syndicate, led by Graphite Ventures and debt partner SWK Holdings Corporation, with participation from Garage Capital, MaRS IAF, Laurier Startup Fund, ArchAngel, GTAN and support from Agilent Technologies, WhiteCap Venture Partners, BDC Capital's Growth & Transition Capital Team, Export Development Canada (EDC) among others. Article content The acquisition directly addresses the biopharmaceutical industry's need for more comprehensive and efficient analytical solutions to accelerate the development of increasingly complex protein-based drugs. By integrating Applied Photophysics's established technologies for protein structure (Circular Dichroism), kinetics (stopped flow) and stability assessment (nanoDSF) with Nicoya's expertise in label-free interaction analysis (Surface Plasmon Resonance), Nicoya now offers customers access to an integrated suite of these key technologies from a single company. This allows researchers, particularly those in large pharma and emerging biotechs with high-throughput needs and automation goals, to gain a more complete understanding of their therapeutic candidates. Article content 'Developing sophisticated molecules like ADCs and bispecific antibodies requires a deep understanding of a candidate's binding, structure, and stability. Obtaining this data efficiently has been a persistent industry challenge,' said Ryan Denomme, CEO of Nicoya. 'This acquisition equips Nicoya to directly address that challenge by unifying these essential analytical techniques. We are providing scientists with a more streamlined path to make informed decisions faster, identify the most promising candidates earlier, and ultimately, improve the probability of success for biologic therapies. Our expanded expertise across multiple analytical tools allows us to better support customers in unraveling the interdependencies between structure, function, and stability for these complex modalities.' Article content The expanded Nicoya platform now provides researchers with: Article content Surface Plasmon Resonance (SPR) for quantifying binding kinetics and affinity. Circular Dichroism (CD) and nanoDSF for analyzing protein secondary structure and thermal stability. Stopped-flow kinetics for monitoring rapid kinetic events and enzyme reactions Article content A significant advantage, particularly in early-stage discovery, is the enhanced capability for high-throughput analysis of biologic candidates directly from crude, unpurified samples using Nicoya's Alto™ (SPR) and Applied Photophysics's SUPR-DSF instruments. This ability to bypass time-consuming purification steps for initial screening allows for quicker identification of promising leads and significantly reduces the resources wasted on candidates that might later fail due to unforeseen biophysical properties. Article content 'For decades, Applied Photophysics has provided the scientific community with trusted technologies for deep biophysical insights,' commented Tim Flanagan, CEO of Applied Photophysics, who will be joining Nicoya in a transitional role. 'Integrating these proven capabilities with Nicoya's SPR platforms and their focus on user-friendly workflow automation will provide researchers with more powerful and efficient solutions to meet today's complex drug development demands.' Article content The ability to generate comprehensive, multi-parameter datasets with this expanded instrument portfolio is also important for the biopharmaceutical industry's increasing adoption of Artificial Intelligence (AI) and Machine Learning (ML) in drug development. Nicoya is standardizing data outputs across its offerings to directly support these initiatives, working with AI-focused biotechs and academic partners to enhance predictive modeling for antibody function and developability. Access to such integrated data is key to training more robust AI models that can better predict the developability and potential clinical success of novel biologics. Article content About Nicoya LifeSciences, Inc. Article content Nicoya is advancing biopharmaceutical breakthroughs by equipping scientists with a powerful, integrated analytical platform for characterizing complex biologics. Following its acquisition of Applied Photophysics, Nicoya uniquely combines its pioneering Surface Plasmon Resonance (SPR) systems, including the high-throughput Alto™, with world-renowned technologies for protein structural analysis (Chirascan™ Circular Dichroism) and kinetic/stability studies (SX™ stopped-flow, SUPR-DSF™). This unified offering provides researchers with a comprehensive understanding of a biologic's critical quality attributes—function, structure, and stability—from a single, expert source. By enabling earlier, more informed decision-making and providing high-quality data crucial for AI-driven drug development, Nicoya empowers its partners to de-risk their pipelines, accelerate the path to clinic, and ultimately deliver life-changing therapies to patients more efficiently. Article content Article content Article content
CTV News
3 hours ago
- CTV News
Nvidia, HPE to build new supercomputer in Germany
SAN FRANCISCO — Nvidia and Hewlett Packard Enterprise said on Tuesday they are partnering with the Leibniz Supercomputing Centre to build a new supercomputer using Nvidia's next-generation chips. The Blue Lion supercomputer, as the project is called, will become available to scientists in early 2027, using Nvidia's 'Vera Rubin' chips. The announcement, made at a supercomputing conference in Hamburg, Germany, follows Nvidia's announcement that the Lawrence Berkeley National Lab in the United States also plans to build a system using the chips next year. Separately, Nvidia also said that Jupiter, another supercomputer using its chips at German national research institute Forschungszentrum Julich, has officially become Europe's fastest system. The deals represent European institutions aiming to stay competitive against the U.S. in supercomputers used for scientific fields from biotechnology to climate research. Long before it became an artificial intelligence powerhouse, Nvidia set out to persuade scientists to use its chips to speed up complex computer problems, such as modeling climate change. Those problems required many precise calculations that could take months at a time. Nvidia is now working to persuade scientists to use artificial intelligence. Those AI systems can take the results of a few precise calculations and use them to make predictions that, while not as accurate as the fully calculated results, can still be useful while taking far less time. Nvidia on Tuesday unveiled what it calls its 'Climate in a Bottle' AI model. In a press briefing, Dion Harris, head of data center product marketing at Nvidia, said scientists will be able to input a few initial conditions such as sea surface temperatures and generate a forecast for 10 to 30 years in the future and see what the weather may be like at any kilometer or so of the earth's surface. 'Researchers will use combined approach of classic physics and AI to resolve turbulent atmospheric flows,' Harris said. 'This technique will allow them to analyze thousands and thousands more scenarios in greater detail than ever before.' (Reporting by Stephen Nellis in San Francisco; Editing by Lincoln Feast.)
National Post
5 hours ago
- National Post
Nationale-Nederlanden Launches FINEOS Claims Online Portal - Personal Injury Portal for Victims
Article content DUBLIN — FINEOS Corporation, ( ASX:FCL) a leading provider of core systems for life, accident, and health insurance, is pleased to announce that its client, Nationale-Nederlanden, has successfully launched its new Personal Injury Portal for victims. The new portal empowers victims of personal injury to securely monitor their claim status, upload necessary documents, and communicate directly with their claims handler, all within a user-friendly real-time digital environment. Article content This innovative solution, developed by Nationale-Nederlanden, is powered by FINEOS Claims APIs, enabling seamless data exchange and efficient transaction management in the background. While Nationale-Nederlanden has developed the portal independently, it leverages the robust data capabilities and transactional strength of the FINEOS Platform. Article content Article content 'The launch of the Personal Injury Portal is a significant step in enhancing transparency and support for victims of personal injury,' said Gert Jan Mijen, Head of Bodily Injury Claims at Nationale-Nederlanden. 'By providing a secure, user-friendly platform, we are making it easier for victims to engage in the claims process while maintaining clear communication with our team.' Article content The portal is designed to initially serve victims with minor injuries, with a phased expansion plan that will allow more victims to access the portal in the coming months. As part of the expansion, Nationale-Nederlanden will actively incorporate feedback from both users and internal teams to further enhance the portal's functionality. Article content FINEOS is proud to support this innovative initiative with its scalable API technology, ensuring that all data exchanges and transactions are processed securely and efficiently. This collaboration demonstrates how the FINEOS Platform can seamlessly integrate with client developed engagement solutions to enhance customer service and operational efficiency. Article content About Nationale-Nederlanden Article content Nationale-Nederlanden is one of the largest insurance companies in the Netherlands, offering a wide range of insurance products and services, including life, disability, and personal injury insurance. Article content About FINEOS Article content Article content Article content
